Last reviewed · How we verify
Medicinal Plant
At a glance
| Generic name | Medicinal Plant |
|---|---|
| Also known as | Treatment Group (TG) |
| Sponsor | Universidade do Vale do Sapucai |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- The Effect of Horticultural Therapy on Loneliness and Life Satisfaction in Elderly Adults Living in Nursing Home (NA)
- Assessing and Addressing Community Exposures to Environmental Contaminants (NA)
- Effect of Golden Rice-Piper Crocatum Cookies on Neuropathy Prevention in Diabetes (NA)
- Efficacy and Safety of NTI164 in Children and Young Adults With Rett Syndrome (PHASE2, PHASE3)
- NTI164 in Autism Spectrum Disorder (PHASE3)
- Symptoms and Physiological Effects of Amara in Functional Dyspepsia (PHASE4)
- Clinical Trial Evaluate the Cough-relieving and Expectorant Effects of the Health Supplement AZKA Nasal and Throat for Children in Outpatient-treated Pharyngitis (NA)
- NTI164 Human PK Study (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Medicinal Plant CI brief — competitive landscape report
- Medicinal Plant updates RSS · CI watch RSS
- Universidade do Vale do Sapucai portfolio CI